Analysts Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) PT at $20.36

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) have been assigned a consensus recommendation of "Hold" from the thirteen research firms that are currently covering the firm, Marketbeat.com reports. Eleven investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $20.36.

A number of brokerages have recently issued reports on XRAY. Mizuho reduced their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Thursday, March 13th. Wall Street Zen lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday. Morgan Stanley lowered shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a research report on Tuesday, April 15th. Piper Sandler dropped their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research report on Wednesday, April 30th. Finally, Barrington Research upped their target price on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an "outperform" rating in a research report on Monday, May 12th.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of hedge funds have recently added to or reduced their stakes in the stock. First Community Trust NA grew its stake in DENTSPLY SIRONA by 66.0% in the 2nd quarter. First Community Trust NA now owns 15,090 shares of the medical instruments supplier's stock worth $240,000 after acquiring an additional 6,000 shares in the last quarter. Kera Capital Partners Inc. bought a new position in DENTSPLY SIRONA in the 2nd quarter worth about $170,000. Focus Partners Wealth grew its stake in DENTSPLY SIRONA by 59.1% in the 1st quarter. Focus Partners Wealth now owns 25,181 shares of the medical instruments supplier's stock worth $376,000 after acquiring an additional 9,355 shares in the last quarter. Bayforest Capital Ltd grew its stake in DENTSPLY SIRONA by 822.2% in the 1st quarter. Bayforest Capital Ltd now owns 20,676 shares of the medical instruments supplier's stock worth $309,000 after acquiring an additional 18,434 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in DENTSPLY SIRONA by 7.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 593,021 shares of the medical instruments supplier's stock worth $8,860,000 after acquiring an additional 41,579 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY traded down $0.73 during trading hours on Friday, hitting $15.94. 2,495,017 shares of the company's stock traded hands, compared to its average volume of 2,937,134. The business's fifty day moving average price is $15.74 and its two-hundred day moving average price is $16.43. The company has a current ratio of 1.10, a quick ratio of 0.76 and a debt-to-equity ratio of 0.79. The firm has a market capitalization of $3.18 billion, a P/E ratio of -3.51, a P/E/G ratio of 1.19 and a beta of 0.94. DENTSPLY SIRONA has a 52 week low of $12.16 and a 52 week high of $27.95.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million during the quarter, compared to analysts' expectations of $854.75 million. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The company's revenue for the quarter was down 7.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.42 earnings per share. Equities research analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be paid a $0.16 dividend. The ex-dividend date is Friday, June 27th. This represents a $0.64 dividend on an annualized basis and a yield of 4.02%. DENTSPLY SIRONA's dividend payout ratio is currently -14.10%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.